Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 March 2023 | Story André Damons | Photo Reuben Maeko
Dr William Mhundwa
Prof Thabiso Mofokeng, Head of Department: Internal Medicine, and Dr Busiswa Bisiwe, Head of the Unit: Nephrology and Dr William Mhundwa’s (right) supervisor, congratulates him on his great achievement.

Dr William Mhundwa, Senior Registrar in the Department of Internal Medicine at the University of the Free State (UFS), has become the first candidate from the institution to be awarded the prestigious Suzman Medal as the top student in the 2022 examinations of the Fellowship of the College of Physicians (FCP).  

Candidates from all medical schools in the country as well as other African countries wrote this examination in January and July 2022. Dr Mhundwa came out on top and was awarded the medal by the Senate of the Colleges of Medicine of South Africa (CMSA), which oversees the examinations.  

“I congratulate Dr Mhundwa on his outstanding performance,” commented Prof Nicholas Pearce, Head of the School: Clinical Medicine at the UFS. According to him, this is a prestigious award, and given that it is the first time that a candidate from this university has been awarded this medal, it is extra special for us as a department, faculty, and institution. 

Dr Mhundwa was born in Harare, Zimbabwe, to subsistence farmers and is the eldest of four boys. He immigrated to South Africa nearly ten years ago and started studying medicine as a way to fulfil his parents’ dreams. He eventually found his calling in internal medicine, specifically nephrology (kidney disease), and would like to obtain further qualifications in this field at the university. 

 “My achievements are the result of dedication to teaching internal medicine consultants. I am indebted to the Free State Department of Health for the opportunity to train and work under them. I hope to see great academic achievements within this province,” says Dr Mhundwa. 

He will graduate in April 2023 with a Master of Medicine, cum laude. His thesis was about The Prevalence of Chronic Kidney Disease Among Type 2 Diabetes Mellitus Patients in Central South Africa

Dr Mhundwa believes “that kidney disease is a scourge in modern society.  Early diagnosis is necessary to prevent patients from requiring kidney transplants and dialysis and to improve the quality of life of my patients”.

Prof Thabiso Mofokeng, Head of Department: Internal Medicine, said, “This achievement represents the UFS’ high academic standards on national front. We hope this is the first of many.”

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept